Tetra Tech Q4 Net Revenue Up 5%, But Growth Remains Modest Amid Structural Shifts

What happened

Tetra Tech reported fiscal Q4 2026 net revenue of $1.15 billion, up 5% year-over-year, with total revenue of $1.34 billion including subcontractor costs. The company's press release frames this as “strong” results, but the growth rate is only in line with the low end of management's prior base-case assumption of 4–6% annual net revenue growth. Crucially, the release does not yet provide granular detail on segment performance, adjusted EPS, or backlog evolution, leaving open whether the core water and defense businesses are truly offsetting the loss of USAID work. Compared to the prior-year quarter, which included significant disaster-response revenue, the 5% growth likely reflects stabilization rather than acceleration. Absent evidence of margin expansion or a rebound in book-to-bill, the result does little to change the fundamental picture of a company still digesting structural revenue loss and legal overhangs.

Implication

Investors should view the 5% net revenue growth as a necessary but insufficient condition for re-rating. The market will need to see sustained acceleration above 6% excluding USAID/disaster work and clear evidence that adjusted EBITDA margin is expanding by at least 30–50 bps before the stock can overcome its current valuation of ~21–22x forward earnings. The lingering risk of another environmental legal charge, as seen in FY25 with the $115M Hunters Point contingency, remains a key downside catalyst that is not addressed in this press release. Additionally, the dependency on government appropriations for water and defense infrastructure means that any future cuts to EPA/SRF funding could stall the recovery. Until management provides a full breakdown of segment margins, RUPO composition, and updated FY27 guidance, the prudent stance is to remain on the sidelines and wait for either a pullback toward $34 or two consecutive quarters of ex-USAID revenue growth above 6% with margin improvement.

Thesis delta

The Q4 FY26 results are consistent with the base-case scenario of mid-single-digit net revenue growth, but do not yet provide evidence that the company is successfully backfilling the USAID hole with higher-margin work. The absence of detailed margin and backlog data means the WAIT rating remains appropriate, with the attractive entry still near $34. A shift to a more constructive stance would require either a pullback in price or clear demonstration of accelerating ex-USAID revenue and margin expansion over the next two quarters.